Effects of Angiotensin II Type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Takemori, Kumiko ^a   Inoue, Takao ^a   Ito, Hiroyuki ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Adipokines; Adipose tissue; Angiotensin II type I receptor blocker; Lipoatrophy; Renin angiotensin system; Stroke prone spontaneously hypertensive rats

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CANDESARTAN; LEPTIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; BRAIN DAMAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EPIDIDYMIS FAT; HEREDITARY HYPERTENSION; HYPERTENSION; INTRAABDOMINAL FAT; LIPOATROPHY; MALE; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT;

ADIPOCYTES; ADIPONECTIN; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERTENSION; KIDNEY; MALE; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; STROKE; TETRAZOLES;

RATTUS;

EID: 84880334503     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-108     Document Type: Article

References (27)

1. Obesity, essential hypertension and renin-angiotensin system. Sequra J, Ruilope LM, Public Health Nutr 2007 10 1151 1155 17903324 (Pubitemid 350089882)
2. Elevated blood pressure in subjects with lipodystrophy. Sattler FR, Qian D, Louie S, Johmson D, Briggs W, DeQuattro V, Dube MP, AIDS 2001 15 2001 2010 10.1097/00002030-200110190-00013 11600829 (Pubitemid 32980643)
3. Lipoatrophy and lipohypertrophy are independently associated with hypertension. Crane HM, Grunfeld C, Harrington RD, Kitahata MM, HIV Med 2009 10 496 503 10.1111/j.1468-1293.2009.00720.x 19486188
4. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system. Auclair M, Vigouroux C, Boccara F, Capel E, Vigeral C, Guerci B, Lascols O, Capeau J, Caron-Debarle M, Arterioscler Thromb Vasc Biol 2013 33 829 838 10.1161/ATVBAHA.112.300962 23393388
5. Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Lamounier-Zepter V, Bornstein SR, Kunes J, Zicha J, Kresk M, Ehrhanrt-Bornstein M, Ziegler CG, Kiessling A, Funk RH, Haluzik M, Mol Cell Endocrinol 2008 280 39 46 10.1016/j.mce.2007.09.012 18045774 (Pubitemid 350184200)
6. Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Takemori K, Gao YJ, Ding L, Lu C, Su LY, An WS, Vinson C, Lee RM, Hypertension 2007 49 365 372 17200435 (Pubitemid 46143014)
7. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiera F, Sharma AM, Int J Biochem Cell Biol 2003 35 807 825 10.1016/S1357-2725(02)00311-4 12676168 (Pubitemid 36379323)
8. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM, Eur J Pharmacol 2006 552 112 122 10.1016/j.ejphar.2006.08.062 17064684 (Pubitemid 44754970)
9. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats. Takemori K, Ishida H, Ito H, Life Sci 2005 77 2233 2245 10.1016/j.lfs.2004.12.048 15963533 (Pubitemid 41169959)
10. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system. Hamaguchi R, Takemori K, Inoue T, Masuno K, Ito H, Clin Exper Pharmacol Physiol 2008 35 1151 1155 10.1111/j.1440-1681.2008.04973.x
11. Angiotensin II type 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Nishimura Y, Ito T, Saavedra JM, Stroke 2000 31 2478 2486 10.1161/01.STR.31.10.2478 11022082
12. Pre-treatment with candesartan protects from cerebral ischemia. Ito T, Nishimura Y, Saavedra JM, J Renin Angiotensin Aldosterone Syst 2001 2 174 179 10.3317/jraas.2001.024 11881119 (Pubitemid 33685888)
13. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. Yamakawa H, Jezzova M, Ando H, Saavedra JM, J Cereb Blood Flow Metab 2003 23 371 380 12621312 (Pubitemid 36307581)
14. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM, Diabetes 2002 51 1699 1707 10.2337/diabetes.51.6.1699 12031955 (Pubitemid 34564280)
15. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M, FASEB J 2001 15 2727 2729 11606482
16. Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, Cavazzini S, Cantoni AM, Scandroglio R, Fiaccadori E, J Clin Endocrinol Metab 2005 90 2888 2897 10.1210/jc.2004-1995 15741261 (Pubitemid 40686340)
17. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A, Diabetes 2005 54 991 999 10.2337/diabetes.54.4.991 15793237 (Pubitemid 40446313)
18. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH, Proc Natl Acad Sci USA 1997 94 4637 4641 10.1073/pnas.94.9.4637 9114043 (Pubitemid 27194295)
19. Leptin reduces infarct size in association with enhanced expression of CB2, TRPV1, SIRT-1 and leptin receptor. Avraham Y, Davidi N, Porat M, Chernoguz D, Magen I, Vorobeiv L, Berry EM, Leker RR, Current Neurovasc Res 2010 7 136 143 10.2174/156720210791184943
20. Leptin-replacement therapy for lipodystrophy. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A, N Engl J Med 2002 346 570 578 10.1056/NEJMoa012437 11856796 (Pubitemid 34438818)
21. Long-term leptin-replacement therapy for lipoatrophic diabetes. Ebihara K, Masuzaki H, Nakao K, N Engl J Med 2004 351 615 616 10.1056/ NEJM200408053510623 15295061 (Pubitemid 39025183)
22. Drug insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Brennan AM, Mantzoros CS, Nat Clin Pract Endocrinol Metab 2006 2 318 327 10.1038/ncpendmet0196 16932309 (Pubitemid 43885911)
23. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Ebihara K, Ogawa Y, Masuzaki H, Shintani M, Miyanaga F, Aizawa-Abe M, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Gavrilova O, Reitman ML, Nakao K, Diabetes 2001 50 1440 1448 10.2337/diabetes.50.6.1440 11375346 (Pubitemid 32500178)
24. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Trayhurn P, Beattie JH, Proc Nutr Soc 2001 60 329 339 10.1079/PNS200194 11681807 (Pubitemid 32772448)
25. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC, Hypertension 2002 40 609 611 10.1161/01.HYP.0000036448.44066.53 12411451 (Pubitemid 35278594)
26. Novel effect of adenosine 5'-monophosphatase on ameliorating hypertension and the metabolism of lipoids and glucose in stroke-prone spontaneously hypertensive rats. Ardiansyah H, Shirakawa H, Koseki T, Hiwatashi K, Takahasi S, Akiyama Y, Komai M, J Agri Food Chem 2011 59 13238 45 10.1021/jf203237c
27. Conjugated linoleic acid improve blood pressure by increasing adiponectin and endothelial nitric oxide synthase activity. DeClercq V, Taylor CG, Wigle J, Wright B, Tworek L, Zahradka P, J Nutr Biochem 2012 23 487 93 10.1016/j.jnutbio.2011.02.003 21684141